Smruti Vidwans, PhD
Chief Science Officer
Dr. Smruti Vidwans is an award-winning researcher and biomedical industry expert who has developed strategies for organizations ranging from pharma giants to drug-discovery startups and nonprofits. At CollabRx, she has driven the development of the molecular disease models, the proprietary Therapy Finder applications in cancers such as melanoma, lung cancer and colorectal cancer as well as the Genetic Variant Annotation product that provides therapeutic interpretation of NGS-derived molecular data. Prior to CollabRx, she was at McKinsey and Company where she worked on a developing a range of business and scientific solutions for the pharmaceutical industry – including clinical trial design and evaluation, R&D process optimization, business strategy implementation, and change management. She has co-founded and consulted with several drug discovery startups. In addition, she has worked in the Tuberculosis drug discovery space for which she was named one of the top 100 young investigators under 35. Dr. Smruti Vidwans holds a SB in Biology from the Massachusetts Institute of Technology, and a PhD in Genetics, Developmental and Molecular Biology from the University of California, San Francisco.